The editorial board of the The Wall Street Journal published this editorial on April 15, 2019. In it, they write:
“The argument that drug importation threatens the integrity of the drug supply is often dismissed because pharmaceutical lobbyists make it. But keeping the drug supply free from contaminated or counterfeit products is not easy, and the World Health Organization has warned that 1 in 10 medical products in the developing world are phony. It isn’t clear who is liable if counterfeits are found in Florida, but you can bet it won’t be the politicians.”
Read More
April 12, 2019 (Tallahassee, FL) — Importation undermines our core efforts to keep our medicine supply safe. State and federal authorities regulate every entity in the U.S. supply chain from the point of manufacture until a medicine is dispensed, and that makes counterfeits in the legitimate supply chain rare. In 2013, Congress passed the Drug…
Read More
In March 2019, the U.S. Food and Drug Administration issued warning letters to a website and an online pharmacy network for selling misbranded mifepristone and misoprostol
Read More
In this editorial, which was published in The Gadsden Times on April 11, 2019, former FDA-OCI director George Karavetsos points out the real dangers of drug importation:
“Even today, Americans are being hurt and even dying because of counterfeit medications being imported into this country. Adding insult to injury, while some might point to Canada as being a safe source, counterfeit medications are transshipped through Canada from other countries in remote corners of the globe.”
Read More
The News and Record has reported about a North Carolina resident, Yazid Al Fayyad Finn, who was arrested in 2018 for his part in a plot to steal a 200 pound shipment of counterfeit Xanax that was being smuggled across the Quebec-Vermont border.
Read MoreWASHINGTON (April 8, 2019) – As members of Congress and leaders in the executive branch consider steps to allow wholesale importation of prescription medications, organizations representing consumers, employers, healthcare professionals, patients, and law enforcement officers, among others, are insisting that such proposals, if implemented, would endanger the health and safety of the communities throughout the country…
Read More
On March 15th, two different busts in Arizona highlighted the problems the Grand Canyon State is having with counterfeit pills.
Read More
The Lake County Crime lab processed more than 250 counterfeit oxycodone tablets, and officials with the lab told the News Herald that such counterfeit pill discoveries are on the rise.
Read More
This editorial by Dan Fucarino was published in Florida Politics on April 1, 2019. Mr Fucarino is the owner and a pharmacist at Carrollwood Compounding Center & Pharmacy.
“The monetary rewards of Canadian prescriptions are just not worth their safety risks,” he warns. “I urge Florida legislators to listen to health care experts on this issue rather than the understandable populist appeals and vote no on this dangerous legislation — and then get back to working on more productive ways to lower drug prices for Floridians. Thousands of Americans have been injured or killed by imported prescription drugs.”
Read More
Immunodeficient patients need to strictly adhere to our prescribed drug protocols because any slip could compromise our current treatment plans. Only purchasing FDA-approved medicines from licensed U.S pharmacies is an essential step in keeping ourselves as healthy as possible…
Read More